Browse the evidence

There is probable evidence that increasing vegetable and fruit consumption does not directly influence the risk of type 2 diabetes mellitus, independent of body weight.

While vegetables and fruit are essential for heart health, they do not directly prevent diabetes. Focus on maintaining a healthy weight and overall diet quality to manage your diabetes risk.

Greenspace exposure is associated with improved pregnancy outcomes, specifically a reduced risk of preterm birth and small size for gestational age.

For pregnant women, living in or frequently visiting areas with higher greenness is associated with a lower risk of preterm birth and having a baby that is small for gestational age. This suggests that environmental factors play a role in pregnancy health.

Caloric restriction (CR) is an effective intervention that impacts aging, age-related pathologies, and longevity in model organisms such as mice and rats.

While this paper confirms caloric restriction extends longevity in mice and rats, it does not provide specific human dosing protocols. For humans, this suggests that avoiding overconsumption and maintaining a healthy weight may support healthy aging, but specific restriction protocols should be discussed with a healthcare provider.

Epigenetic clocks, such as the DNAm PhenoAge and DunedinPoAm, can predict biological age, lifespan, and risk of chronic disease.

Epigenetic clocks are emerging tools to measure biological aging. While not yet standard clinical practice, they may eventually help individuals track the impact of lifestyle changes on their biological age.

Obstructive sleep apnea (OSA) is associated with an increased risk of incident heart failure in community-dwelling middle-aged and older men, but not in women.

If you are a man over 40, getting your sleep apnea treated is a critical step for heart health, even if you don't have other symptoms. The study shows that untreated OSA significantly increases the risk of developing heart failure. Women in this study did not show the same risk association, possibly due to later onset or hormonal protection, but men should prioritize diagnosis and treatment (like CPAP) to protect their heart.

The association between OSA and incident coronary heart disease (CHD) is weaker and less consistent than for heart failure, and was only nominally significant in men under 70 in this community-based study.

For men under 70, treating OSA may offer some protection against coronary heart disease, but the benefit is modest compared to its clear benefit for preventing heart failure. If you are over 70, the link to CHD is not statistically significant in this study. Focus on treating OSA primarily for heart failure prevention and overall sleep quality, rather than solely for CHD prevention.

In centenarians, gut microbiota composition shifts significantly toward facultative anaerobes (Proteobacteria, Bacilli) and decreases in symbiotic anti-inflammatory species (Faecalibacterium prausnitzii), which is associated with a highly inflamed status (inflammageing).

This research highlights that extreme longevity is associated with a unique gut microbiome profile characterized by lower diversity and higher levels of certain opportunistic bacteria, alongside lower levels of beneficial anti-inflammatory species. For general health, maintaining a diverse microbiome rich in symbiotic bacteria (like Faecalibacterium) through diet and lifestyle may help mitigate age-related inflammation, though specific interventions for centenarians are not yet defined.

Severe sleep-disordered breathing (AHI ≥30 events/h) is independently associated with increased all-cause and coronary artery disease mortality in men aged 40–70, mediated by intermittent hypoxemia rather than sleep fragmentation.

If you are a man between 40 and 70, getting tested for severe sleep apnea (AHI ≥30) is critical for longevity. The risk of death from heart disease and other causes doubles in this group, driven by low oxygen levels during sleep, not just poor sleep quality. Women and older men (>70) do not show the same strong link to mortality in this study, but severe cases in women still warrant attention.

The global prevalence of sarcopenia varies significantly (10-27%) depending on the diagnostic classification and measurement instrument used, with no single standardized criterion currently established.

Because there is no single standard for diagnosing sarcopenia, prevalence rates you see in media or different clinics will vary widely (10-27%). If you are concerned about muscle loss, ask your provider which diagnostic criteria they are using (e.g., EWGSOP2) and which tool (DXA or BIA) they used, as this determines the result. Consistency in testing is more important than comparing your result to a global average.

The prevalence of severe sarcopenia ranges from 2% to 9% globally, with higher rates observed in European studies using EWGSOP criteria compared to Asian/Oceanic studies using other classifications.

Severe sarcopenia, which combines low muscle mass with poor physical performance (like slow gait speed), affects 2-9% of the population depending on how it is measured. It is a stronger predictor of mortality than sarcopenia alone, so early identification using standardized performance tests is critical.

Gut microbiota composition and activity influence host metabolism and immune function through mechanisms involving short-chain fatty acids (SCFAs) and bacterial endotoxins (LPS), but causal links are often confounded by environmental factors and relative abundance analysis errors.

Focus on dietary habits and lifestyle factors that support a diverse and active gut microbiome, such as consuming fermentable dietary fibers and maintaining healthy body weight. Be cautious of claims that specific single bacteria are universally 'good' or 'bad'; their effects depend on your diet and health status. Prioritize whole-food diets over isolated probiotic supplements for long-term gut health.

A higher difference between DNA methylation-predicted age and chronological age (Δage) is associated with a significantly increased risk of all-cause mortality in older adults, independent of known health and lifestyle risk factors.

Your biological age, as measured by DNA methylation patterns, may be a better predictor of your lifespan than your actual age. A higher 'epigenetic age' (meaning your DNA looks older than your chronological age) is linked to a higher risk of death, even if you don't have common diseases like diabetes or high blood pressure. While you cannot directly 'take' this biomarker, the finding suggests that maintaining health through lifestyle factors might help keep your biological age closer to your chronological age, potentially reducing mortality risk.

Sarcopenia (loss of muscle mass) is not universally associated with disability or mortality; low muscle strength is a more consistent predictor of these negative outcomes.

Don't just worry about your muscle size. Focus on maintaining your strength through resistance training. Studies show that low strength, not just low muscle mass, is what puts you at risk for disability and death. Prioritize exercises that build force production.

Chronic, low-grade inflammation (inflamm-aging) driven by cytokine dysregulation, oxidative stress, and senescent cells is a primary mechanism underlying aging and age-related diseases such as cardiovascular disease, diabetes, and neurodegeneration.

Focus on lifestyle factors that reduce chronic inflammation: adopt a Mediterranean-style diet rich in omega-3s, engage in regular exercise to upregulate autophagy, and manage stress. These approaches support the body's natural resolution of inflammation rather than just suppressing symptoms.

Senescent cells contribute to aging and age-related diseases through the Senescence-Associated Secretory Phenotype (SASP), which promotes a pro-inflammatory milieu.

While direct 'senolytic' treatments are not yet standard, lifestyle factors that reduce cellular stress (exercise, healthy diet) may help minimize the accumulation of senescent cells.

Epigenetic clocks (DNAmAge) are currently the most robust biological age predictors, strongly correlating with chronological age and independently predicting all-cause mortality, cancer mortality, and various aging phenotypes such as frailty and cognitive decline.

Chronological age is not your destiny. Biomarkers like DNA methylation (epigenetic clocks) show that your body's biological state can differ significantly from your birth year. While you cannot change your birth date, these markers suggest that your health trajectory is influenced by factors like inflammation, immune function, and lifestyle. Monitoring these biological ages (where available) may offer more insight into your health risks than age alone, highlighting the importance of maintaining metabolic health and managing inflammation to potentially slow biological aging.

The accumulation of senescent cells and their Secretory Phenotype (SASP) drives chronic inflammation (inflammaging) and contributes to age-related tissue dysfunction.

Chronic low-grade inflammation is a key driver of aging. Research suggests that this inflammation is partly caused by the accumulation of senescent cells. Therapies that clear these cells have been shown to reduce inflammatory markers in animal models.

Overtraining syndrome (OTS) is diagnosed retrospectively through the exclusion of organic diseases and other stressors, as no single diagnostic marker currently exists to definitively identify it.

If you are an athlete experiencing prolonged performance decline and fatigue, do not look for a single 'overtraining test.' Instead, work with medical professionals to rule out other causes like anemia, thyroid issues, or infections. Focus on identifying and managing non-training stressors (sleep, life stress) and ensuring adequate nutrition, as these are key contributors to the syndrome.

Roux-en-Y gastric bypass (RYGB) surgery induces rapid, starvation-like adaptations in gut microbiota composition, specifically increasing Bacteroides/Prevotella and E. coli while decreasing Lactobacillus and Bifidobacterium, which correlates with reduced body fat and leptin levels independently of caloric intake for some species.

Bariatric surgery like RYGB triggers a rapid reorganization of gut bacteria that mirrors a starvation response, helping to reduce body fat and inflammation. This happens partly because the surgery changes gut pH and bile flow, not just because you eat less. For obese individuals, this microbial shift is a key part of why metabolic health improves so quickly after surgery.

Dietary fiber fermentation by gut microbiota produces short-chain fatty acids (SCFAs) which activate specific receptors (GPR41, GPR43, GPR109A) to regulate energy expenditure, lipid homeostasis, and inflammation.

Prioritize diverse sources of dietary fiber to support gut bacteria that produce SCFAs. These microbial byproducts act as signals to regulate your metabolism and reduce inflammation, offering benefits beyond simple caloric intake.

Non-caloric artificial sweeteners (NAS) induce glucose intolerance by altering gut microbiota composition, and these effects can be reversed by antibiotics.

Be cautious with non-caloric artificial sweeteners, as they may negatively impact glucose tolerance by altering your gut microbiome. Opt for whole foods or unsweetened beverages when possible.

Phytochemicals provide health benefits through specific biochemical mechanisms, but efficacy must be demonstrated in vivo, as in vitro and animal studies alone are insufficient to claim disease prevention in humans.

Do not rely on isolated phytochemical supplements to treat or prevent disease based solely on lab studies. While plant compounds like polyphenols and terpenes have known mechanisms (e.g., antioxidant, anti-inflammatory), their actual benefit in humans depends on absorption and metabolism. Focus on whole food sources (fruits, vegetables, grains) rather than isolated extracts, as the synergy and bioavailability in whole foods are better understood than in isolated nutraceuticals.

DNA methylation clocks are highly accurate molecular correlates of chronological age in humans and vertebrates, but their ability to quantify biological aging rates and test longevity interventions is currently limited by challenges in distinguishing chronological from biological components and understanding underlying mechanisms.

DNA methylation clocks are currently best used as precise tools for estimating chronological age, particularly in forensic or large-scale epidemiological contexts. Their use for evaluating anti-aging interventions is still experimental and requires specialized, tissue-specific clocks rather than general 'pan-tissue' clocks. Individuals should not rely on current commercial epigenetic age tests for making definitive health decisions regarding longevity interventions, as the scientific community acknowledges significant unresolved challenges in distinguishing true biological aging from chronological age effects.

Antibiotic administration, particularly broad-spectrum fluoroquinolones, disrupts the gut microbiome by reducing secondary bile acid-producing bacteria (e.g., C. scindens), which removes the inhibition on Clostridium difficile vegetative growth and leads to infection.

Be cautious with broad-spectrum antibiotics, especially fluoroquinolones, as they can wipe out the specific bacteria that produce secondary bile acids. These bile acids normally inhibit C. difficile. If you must take antibiotics, discuss probiotic or dietary strategies to support your gut microbiome afterward, as this disruption is a primary cause of post-antibiotic diarrhea and CDI.